Related references
Note: Only part of the references are listed.Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'
Helen S. Goodridge et al.
NATURE (2011)
Principles of Source Control in the Early Management of Sepsis
John C. Marshall
Current Infectious Disease Reports (2010)
Combined yeast-derived β-glucan with anti-tumor monoclonal antibody for cancer immunotherapy
Jingjing Liu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Sex differences in response to immunonutrition in sepsis
Tsann-Long Hwang et al.
NUTRITION (2008)
Mobilization of hematopoietic progenitor cells by yeast-derived β-glucan requires activation of matrix metalloproteinase-9
Daniel E. Cramer et al.
STEM CELLS (2008)
Polymicrobial sepsis enhances clearance of apoptotic immune cells by splenic macrophages
Ryan Swan et al.
SURGERY (2007)
Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways
Bing Li et al.
CLINICAL IMMUNOLOGY (2007)
Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality
Marcin F. Osuchowski et al.
JOURNAL OF IMMUNOLOGY (2006)
The effect of PGG-β-glucan on neutrophil chemotaxis in vivo
Brian W. LeBlanc et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels
D Vyas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge
PJ Rice et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Role of interleukin-6 in mortality from and physiologic response to sepsis
DG Remick et al.
INFECTION AND IMMUNITY (2005)
Transcriptional inhibition of interleukin-8 expression in tumor necrosis factor-tolerant cells -: Evidence for involvement of C/EBPβ
M Weber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages
CJ Godshall et al.
SHOCK (2003)
Six at six: Interleukin-6 measured 6 H after the initiation of sepsis predicts mortality over 3 days
DG Remick et al.
SHOCK (2002)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
